| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |